The ExPAND Policy Toolkit on Diabetes

Diabetes costs healthcare systems more than all cancers combined, yet policy action lags behind other areas of healthcare.

Context

Diabetes kills more people in Europe than breast cancer and prostate cancer together.  

Despite the considerable toll of diabetes, funding and action lags behind other chronic conditions such as cancer and cardiovascular disease. 

The clock is ticking: ageing populations and rising obesity mean type 2 diabetes is on the increase. Type 1 diabetes is also on the rise, especially in children. 

Despite robust evidence, policy recommendations and international declarations, not enough is being done to combat diabetes in Europe. 

Download project output

 

1 in 10 people will have diabetes by 2035

Up to 50% of all cases of diabetes in Europe are undiagnosed

Diabetes leads to a 3–5 times greater risk of heart disease and doubles the risk of stroke

What we achieved

HPP led the creation of the European Policy Action Network on Diabetes (ExPAND) in 2011, to bring together Members of Parliament, Members of the European Parliament and diabetes stakeholders from across Europe. We provided expert research and secretariat support for ExPAND to create Europe’s leading diabetes policy toolkit, offering a whole-system vision for comprehensive diabetes prevention and care.

The ExPAND Policy Toolkit on Diabetes has been translated into several languages and used as a starting point for policy change in countries across Europe. It is endorsed by the Foundation of European Nurses in Diabetes (FEND) and Primary Care Diabetes Europe (PCDE).

ExPAND continues to operate under the International Diabetes Federation Europe.

Key partners and stakeholders

  • International Diabetes Federation Europe

The project was initiated and funded by Bristol-Myers Squibb and AstraZeneca.